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The House of Lords must alert the government about evidence showing that 
“long covid” (which includes debilitating fatigue and negative health effects) 
might last for years among sufferers, posing a long-term risk to the nation’s 
workforce and economy. This report discusses evidence that viruses can trigger 
long-term fatigue that severely impairs the personal and occupational 
functioning of sufferers, including evidence from populations affected by SARS-
CoV-1 where 1 in 4 had debilitating chronic fatigue lasting over 4 years later. 
Due to post-viral chronic fatigue being a condition that can force people into 
becoming housebound or unable to work, the House of Lords must alert the 
government of the risks currently facing people within the UK who were infected 
with covid-10:
Key points
• There is the risk of higher unemployment rates among people who had 
covid-19.
• There is the risk of higher underemployment rates among people who 
had covid-19 e.g., more switching to part-time working or lower skilled 
jobs because of health problems.
• There is the risk of future staff shortages in occupations with a high 
prevalence of covid-19.
Risk of debilitating fatigue after covid-19 infection
Up to 1 in 5 of people infected with covid-19 develop a series of sporadic and 
changing symptoms such as chronic fatigue, headaches, respiratory, metabolic, 
muscular and neurocognitive symptoms (e.g. “brain fog”) that last for a long 
time.1,2 The suit of symptoms has been called “long covid” but it is important to 
note that the chronic fatigue element of long covid is particularly concerning for 
the government. This is because it is the most prevalent and continuous 
symptom, reported by 98% of people with long covid.1 The highly concerning 
prevalence rate of chronic fatigue among people who had covid-19 replicates 
evidence from previous viral epidemics where it too was a notable outcome e.g., 
40% of people with the previous severe acute respiratory syndrome coronavirus 
outbreak (SARS-CoV-1) continued to suffer from chronic fatigue as much as 4 
years after the viral infection.3 27.1% of people with SARS-CoV-1 had fatigue so 
severe and life-changing in its debilitating effects on occupational/other 
functioning that it met the diagnostic criteria for a medical condition known as 
myalgic encephalomyelitis (ME) or chronic fatigue syndrome (CFS) as much as 4 
years on. 
Risk of becoming housebound or unable to work after covid-19 infection
This is a severe risk to people’s health and the national economy because a 
quarter of CFS/ME sufferers are made bedbound or housebound by the 
debilitating fatigue, over half are unemployed, and many suffer a quality of life 
worse than conditions such as strokes or cancer.5 The government must be 
made aware of evidence that this is an urgent priority because of the 
coronavirus pandemic of 2020/21; whereas CFS/ME is prevalent among only 
1.4%±1.57%.of the general population,5 its prevalence among the people 
infected with SARS-CoV-1 outbreak was significantly higher at 27.1%.3 SARS-
CoV-1 is not alone in inducing debilitating post-viral fatigue that can last months 
or years; other viruses can have a similar effect e.g. the west Nile virus, Epstein-
Barr virus and infectious mononucleosis4 where the prevalence of CFS/ME is also 
markedly higher than the general population. It is thought within the medical 
literature that chronic fatigue might be a consequence of the body’s immune 
response to a virus, with some people more at risk than others but the risk 
cannot simply be predicted by considering the severity of the covid-19 
symptoms; some people who experienced only mild symptoms of covid-19 went 
on to develop long covid.2 
Key point
• Based on the evidence, this report encourages the government to 
measure the percentage of people who developed CFS/ME after being infected 
with covid-19.
How the government can assess and mitigate the risks to the UK 
workforce
The House of Lords Select Committee on Risk Assessment and Risk Planning 
should ask the government to:
A. Conduct research (such as through Office for National Statistics surveys) 
revealing the prevalence of post-covid-19 CFS/ME by asking people who 
had covid-19 questions about key symptoms e.g., debilitating fatigue over 
≥6 months, and following them up for months/years.
B. The government should use the above data in computational modelling 
that estimates the risk of post-covid-19 CFS/ME across the population and 
the risk by occupation, to identify high risk groups and forecast future 
workforce shortages. 
C. The government should target interventions against staff shortages, 
unemployment and underemployment with a focus on occupations at high 
risk of post-covid-19 CFS/ME. If, for example, medical doctors and nurses 
are high risk groups because many caught covid-19 and therefore long 
covid is more prevalent among them, the government can mitigate the 
risk of future workforce shortages through higher investment in medical 
and nursing education.
D. The government should issue guidance (such as through the Department 
of Health) to NHS primary and social care staff about how to diagnose and 
advise people with post-covid-19 CFS/ME. CFS/ME comprises of chronic 
fatigue, “brain fog”, muscle or joint pain, headaches, nausea, sore throats 
and finding it difficult to stay standing or sitting up6 – many of these 
symptoms echo those of long covid therefore there might be a problem of 
underdiagnosis. Although there is no known cure, appropriate diagnosis 
and advice can be helpful.7 
E. The government should provide employers with occupational health 
guidance to help them better support employees infected with covid-19 
who are suffering from chronic fatigue and other negative health effects 
stretching months or years. The guidance should include advice for self-
employed workers.
F. The government should (such as through the Department of Health) 
encourage universities and organisations involved with developing 
vaccines, artificial antibodies and treatments for covid-19 to investigate 
ways of preventing or treating post-covid-19 CFS/ME.
Key point
The government should measure prevalence of post-covid-19 CFS/ME, conduct 
modelling to assess high risk occupational groups, intervene to prevent 
unemployment, underemployment and workforce shortages, guide healthcare 
staff, advise employers/workers, and inspire research into prevention of post-
covid-19 CFS/ME.
Why this risk is an urgent government priority
With half of CFS/ME sufferers unemployed, a quarter rendered bedbound or 
housebound, and many suffering a worse quality of life than people with stroke 
or cancer,5 and given that many people developed CFS/ME after previous viral 
epidemics (e.g., SARS-CoV-1), the implications for the United Kingdom’s 
government are quite serious and urgent. Hundreds of thousands of people are 
potentially at risk, considering the numbers infected with covid-19 and the 
numbers likely to develop long covid by the end of the pandemic (which might 
last years). Even after controlling for other variables arising from the pandemic 
that predict unemployment (e.g., business closures or redundancies because of 
the pandemic), underemployment (e.g. caring responsibilities arising from the 
pandemic that force workers to work part-time) or workforce shortages (e.g., 
halting skills training or recruitment because of the pandemic) it is very likely 
that the coronavirus pandemic will leave a damaging legacy significantly 
attributable to post-covid-19 CFS/ME. The House of Lords should ask the 
government to act now to assess the risks and plan interventions that will 
protect the UK’s workforce by reducing the risk of unemployment, 
underemployment and staff shortages.
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